Inequality in treatment use among elderly patients with acute myocardial infarction

USA, Belgium and Quebec

Julian Perelman, Amir Shmueli, Kathryn M. McDonald, Louise Pilote, Olga Saynina, Marie Christine Closon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background. Previous research has provided evidence that socioeconomic status has an impact on invasive treatments use after acute myocardial infarction. In this paper, we compare the socioeconomic inequality in the use of high-technology diagnosis and treatment after acute myocardial infarction between the US, Quebec and Belgium paying special attention to financial incentives and regulations as explanatory factors. Methods. We examined hospital-discharge abstracts for all patients older than 65 who were admitted to hospitals during the 1993-1998 period in the US, Quebec and Belgium with a primary diagnosis of acute myocardial infarction. Patients' income data were imputed from the median incomes of their residential area. For each country, we compared the risk-adjusted probability of undergoing each procedure between socioeconomic categories measured by the patient's area median income. Results. Our findings indicate that income-related inequality exists in the use of high-technology treatment and diagnosis techniques that is not justified by differences in patients' health characteristics. Those inequalities are largely explained, in the US and Quebec, by inequalities in distances to hospitals with on-site cardiac facilities. However, in both Belgium and the US, inequalities persist among patients admitted to hospitals with on-site cardiac facilities, rejecting the hospital location effect as the single explanation for inequalities. Meanwhile, inequality levels diverge across countries (higher in the US and in Belgium, extremely low in Quebec). Conclusion. The findings support the hypothesis that income-related inequality in treatment for AMI exists and is likely to be affected by a country's system of health care.

Original languageEnglish
Article number130
JournalBMC Health Services Research
Volume9
DOIs
Publication statusPublished - 7 Sep 2009

Fingerprint

Quebec
Belgium
Myocardial Infarction
Therapeutics
Technology
Social Class
Motivation
Delivery of Health Care
Health
Research

Cite this

Perelman, Julian ; Shmueli, Amir ; McDonald, Kathryn M. ; Pilote, Louise ; Saynina, Olga ; Closon, Marie Christine. / Inequality in treatment use among elderly patients with acute myocardial infarction : USA, Belgium and Quebec. In: BMC Health Services Research. 2009 ; Vol. 9.
@article{726c4550450744db98aace3789da5df3,
title = "Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec",
abstract = "Background. Previous research has provided evidence that socioeconomic status has an impact on invasive treatments use after acute myocardial infarction. In this paper, we compare the socioeconomic inequality in the use of high-technology diagnosis and treatment after acute myocardial infarction between the US, Quebec and Belgium paying special attention to financial incentives and regulations as explanatory factors. Methods. We examined hospital-discharge abstracts for all patients older than 65 who were admitted to hospitals during the 1993-1998 period in the US, Quebec and Belgium with a primary diagnosis of acute myocardial infarction. Patients' income data were imputed from the median incomes of their residential area. For each country, we compared the risk-adjusted probability of undergoing each procedure between socioeconomic categories measured by the patient's area median income. Results. Our findings indicate that income-related inequality exists in the use of high-technology treatment and diagnosis techniques that is not justified by differences in patients' health characteristics. Those inequalities are largely explained, in the US and Quebec, by inequalities in distances to hospitals with on-site cardiac facilities. However, in both Belgium and the US, inequalities persist among patients admitted to hospitals with on-site cardiac facilities, rejecting the hospital location effect as the single explanation for inequalities. Meanwhile, inequality levels diverge across countries (higher in the US and in Belgium, extremely low in Quebec). Conclusion. The findings support the hypothesis that income-related inequality in treatment for AMI exists and is likely to be affected by a country's system of health care.",
author = "Julian Perelman and Amir Shmueli and McDonald, {Kathryn M.} and Louise Pilote and Olga Saynina and Closon, {Marie Christine}",
year = "2009",
month = "9",
day = "7",
doi = "10.1186/1472-6963-9-130",
language = "English",
volume = "9",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "Springer Verlag",

}

Inequality in treatment use among elderly patients with acute myocardial infarction : USA, Belgium and Quebec. / Perelman, Julian; Shmueli, Amir; McDonald, Kathryn M.; Pilote, Louise; Saynina, Olga; Closon, Marie Christine.

In: BMC Health Services Research, Vol. 9, 130, 07.09.2009.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inequality in treatment use among elderly patients with acute myocardial infarction

T2 - USA, Belgium and Quebec

AU - Perelman, Julian

AU - Shmueli, Amir

AU - McDonald, Kathryn M.

AU - Pilote, Louise

AU - Saynina, Olga

AU - Closon, Marie Christine

PY - 2009/9/7

Y1 - 2009/9/7

N2 - Background. Previous research has provided evidence that socioeconomic status has an impact on invasive treatments use after acute myocardial infarction. In this paper, we compare the socioeconomic inequality in the use of high-technology diagnosis and treatment after acute myocardial infarction between the US, Quebec and Belgium paying special attention to financial incentives and regulations as explanatory factors. Methods. We examined hospital-discharge abstracts for all patients older than 65 who were admitted to hospitals during the 1993-1998 period in the US, Quebec and Belgium with a primary diagnosis of acute myocardial infarction. Patients' income data were imputed from the median incomes of their residential area. For each country, we compared the risk-adjusted probability of undergoing each procedure between socioeconomic categories measured by the patient's area median income. Results. Our findings indicate that income-related inequality exists in the use of high-technology treatment and diagnosis techniques that is not justified by differences in patients' health characteristics. Those inequalities are largely explained, in the US and Quebec, by inequalities in distances to hospitals with on-site cardiac facilities. However, in both Belgium and the US, inequalities persist among patients admitted to hospitals with on-site cardiac facilities, rejecting the hospital location effect as the single explanation for inequalities. Meanwhile, inequality levels diverge across countries (higher in the US and in Belgium, extremely low in Quebec). Conclusion. The findings support the hypothesis that income-related inequality in treatment for AMI exists and is likely to be affected by a country's system of health care.

AB - Background. Previous research has provided evidence that socioeconomic status has an impact on invasive treatments use after acute myocardial infarction. In this paper, we compare the socioeconomic inequality in the use of high-technology diagnosis and treatment after acute myocardial infarction between the US, Quebec and Belgium paying special attention to financial incentives and regulations as explanatory factors. Methods. We examined hospital-discharge abstracts for all patients older than 65 who were admitted to hospitals during the 1993-1998 period in the US, Quebec and Belgium with a primary diagnosis of acute myocardial infarction. Patients' income data were imputed from the median incomes of their residential area. For each country, we compared the risk-adjusted probability of undergoing each procedure between socioeconomic categories measured by the patient's area median income. Results. Our findings indicate that income-related inequality exists in the use of high-technology treatment and diagnosis techniques that is not justified by differences in patients' health characteristics. Those inequalities are largely explained, in the US and Quebec, by inequalities in distances to hospitals with on-site cardiac facilities. However, in both Belgium and the US, inequalities persist among patients admitted to hospitals with on-site cardiac facilities, rejecting the hospital location effect as the single explanation for inequalities. Meanwhile, inequality levels diverge across countries (higher in the US and in Belgium, extremely low in Quebec). Conclusion. The findings support the hypothesis that income-related inequality in treatment for AMI exists and is likely to be affected by a country's system of health care.

UR - http://www.scopus.com/inward/record.url?scp=69549101732&partnerID=8YFLogxK

U2 - 10.1186/1472-6963-9-130

DO - 10.1186/1472-6963-9-130

M3 - Article

VL - 9

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

M1 - 130

ER -